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Abstract 
Chronic nonpathological pancreatic hyperenzymemia is characterized by a chronic, 
abnormal increase in the serum concentrations of the pancreatic enzymes including 
amylase, pancreatic isoamylase, lipase and trypsin. The diagnostic work-up that the 
physicians should recommend to subjects with hyperenzymemia to definitively assess 
this syndrome is still an open question. A 72-year-old female was admitted to our 
Pancreas Unit in December 2008 for the presence of long-standing pancreatic 
hyperenzymemia of 42 years duration. On admission, serum amylase activity was 160 IU/l 
(reference range 8–78 IU/l), serum pancreatic isoamylase activity was 91 IU/l (reference 
range 13–53 IU/l) and serum lipase activity was 127 IU/l (reference range 8–78 IU/l). 
Other laboratory examinations revealed normal blood tests except for total serum 
cholesterol, HDL cholesterol and serum triglycerides that was slight elevated. Abdominal 
ultrasonography demonstrated no alteration of the pancreatic gland. A magnetic 
resonance cholangiopancreatography was carried out according to our diagnostic 
work-up of patients with unexplained pancreatic hyperenzymemia. This examination 
revealed two small cystic lesions: one of 6 mm in diameter in the head of the pancreas 
and the other one of 9 mm in diameter in the body of the pancreatic gland. The duct of 
Wirsung was normal and the two cystic lesions were diagnosed as branch-type 
intrapapillary mucinous tumors of the pancreas. All patients with pancreatic 
hyperenzymemia should be strictly followed in high volume centers for pancreatic 
disease in order to early diagnose the possible appearance of morphological pancreatic 
alterations. 
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Introduction 
Chronic nonpathological pancreatic hyperenzymemia is characterized by a chronic, 
abnormal increase in the serum concentrations of the pancreatic enzymes including 
amylase, pancreatic isoamylase, lipase and trypsin [1–3]. The diagnostic work-up that the 
physicians should recommend to subjects with hyperenzymemia to definitively assess this 
syndrome is still an open question. We report a patient, who gave written informed 
consent for publication of her case, in whom branch-type intrapapillary tumor of the 
pancreas was found more than 40 years after the diagnosis of benign pancreatic 
hyperenzymemia. 
Case Report 
A 72-year-old female was admitted to our Pancreas Unit in December 2008 for the presence of 
long-standing pancreatic hyperenzymemia of 42 years duration. She was no drinker and had smoked 
about five cigarettes per day from the age of eighteen to the age of fifty. At the age of 30 years, arterial 
hypertension was diagnosed and the patient was treated from then until now with metoprolol at a 
dosage of 100 mg per day. On this occasion, she underwent routine blood analysis which showed a 
hyperamylasemia. Then she underwent, at least two times per year, determination of serum amylase for 
22 years that resulted in the major part of assays elevated with sporadic normalization. For the 
subsequent 20 years (until now) amylase, pancreatic isoamylase and lipase were yearly determined on 
serum and the levels of these three enzymes were always elevated, ranging from 1.5 to 10 times the 
upper reference limit. Twenty years ago, at the age of 52 years, she underwent for the first time 
abdominal ultrasonography that showed a normal pancreatic gland. This examination was repeated 
yearly and it always showed a normal appearance of the pancreas. Thus, the patients had a diagnosis of 
chronic nonpathological pancreatic hyperenzymemia. On admission to our Pancreas Unit physical 
examination was normal, arterial pressure was 140/80 mm Hg, and cardiac rate was 74 beats per 
minute. Laboratory examination revealed normal blood tests: white blood cell count, hemoglobin, mean 
cellular volume, hematocrit, and platelet count; renal and hepatic functions (AST, ALT, GGT and 
alkaline phosphates) were also normal as well as plasma glucose, serum carcinoembryonic antigen, and 
serum CA 19-9. Total serum cholesterol was slight elevated at 225 mg/dl (upper reference limit 
200 mg/dl), HDL cholesterol was 97 mg/dl (lower reference limit 45 mg/dl) and serum triglycerides 
were 93 mg/dl (upper reference limit 180 mg/dl). Serum amylase activity was 160 IU/l (reference range 
8–78 IU/l), serum pancreatic isoamylase activity was 91 IU/l (reference range 13–53 IU/l) and serum 
lipase activity was 127 IU/l (reference range 8–78 IU/l). Abdominal ultrasonography demonstrated no 
alteration of the pancreatic gland (fig. 1). A magnetic resonance cholangiopancreatography was carried 
out according to our diagnostic work-up of patients with unexplained pancreatic hyperenzymemia. This 
examination revealed two small cystic lesions: one of 6 mm in diameter in the head of the pancreas 
(fig. 2) and the other one of 9 mm in diameter in the body of the pancreatic gland (fig. 3). The duct of 
Wirsung was normal and the two cystic lesions were diagnosed as branch-type intrapapillary mucinous 
tumors of the pancreas (fig. 4). 
Discussion 
To our knowledge this is the first case of long-standing pancreatic hyperenzymemia in 
a patient diagnosed as chronic nonpathological pancreatic hyperenzymemia in whom an 
intrapapillary mucinous tumor of the pancreas has been found after the initial diagnosis. 
It has been reported by Mortelé et al. [4] that a careful follow-up with imaging techniques 
should be carried out in patients with asymptomatic pancreatic hyperenzymemia. These 
authors reported pancreatic benign alteration at magnetic resonance 
cholangiopancreatography in more than 50% of patients with chronic asymptomatic 
hyperenzymemia. Thus, it is likely that chronic asymptomatic hyperenzymemia may be 
the sign of underlying benign pancreatic disease; this behavior may also be extended to 
subjects with familial hyperenzymemia [5]. In conclusion, we suggest that all patients 
with pancreatic hyperenzymemia should be strictly followed in high volume centers for  
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pancreatic disease in order to early diagnose the possible appearance of morphological 
pancreatic alterations. 
 
 
 
 
 
Fig. 1. Normal appearance of the pancreas at ultrasonography examination. 
 
 
 
Fig. 2. Magnetic resonance image showing branch-type intrapapillary mucinous tumors of the body of 
the pancreas. 
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Fig. 3. Magnetic resonance image showing branch-type intrapapillary mucinous tumors of the head of 
the pancreas. 
 
 
 
Fig. 4. Magnetic resonance cholangio-Wirsungpancreatography showing branch-type intrapapillary 
mucinous tumors localized in the head and in the body of the pancreas (arrows). 
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